| Literature DB >> 25667026 |
Andres Acosta1, Michael Camilleri2.
Abstract
Prokinetic agents are medications that enhance coordinated gastrointestinal motility and transit of content in the gastrointestinal tract, mainly by amplifying and coordinating the gastrointestinal muscular contractions. In addition to dietary therapy, prokinetic therapy should be considered as a means to improve gastric emptying and symptoms of gastroparesis, balancing benefits and risks of treatment. In the United States, metoclopramide remains the first-line prokinetic therapy, because it is the only approved medication for gastroparesis. Newer agents are being developed for the management of gastroparesis. This article provides detailed information about prokinetic agents for the treatment of gastroparesis.Entities:
Keywords: Domperidone; Erythromycin; Ghrelin; Metoclopramide; Pharmacology; Pyridostigmine; Receptor; Relamorelin; Serotonin
Mesh:
Substances:
Year: 2014 PMID: 25667026 DOI: 10.1016/j.gtc.2014.11.008
Source DB: PubMed Journal: Gastroenterol Clin North Am ISSN: 0889-8553 Impact factor: 3.806